FR12C0005I2 - Utilisation d'une composition estroprogestative en tant que contraceptif oral - Google Patents

Utilisation d'une composition estroprogestative en tant que contraceptif oral

Info

Publication number: FR12C0005I2
Authority: FR; France
Prior art keywords: estrogen; oral contraceptive; progestogen composition; progestogen; composition
Prior art date: 1996-10-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR12C0005C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Laboratoire Theramex SAM

Original Assignee

Laboratoire Theramex SAM

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-08

Filing date

2012-01-19

Publication date

2016-06-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9496456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR12C0005(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-01-19 Application filed by Laboratoire Theramex SAM filed Critical Laboratoire Theramex SAM

2012-02-24 Publication of FR12C0005I1 publication Critical patent/FR12C0005I1/fr

2016-06-24 Application granted granted Critical

2016-06-24 Publication of FR12C0005I2 publication Critical patent/FR12C0005I2/fr

Status Active legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Orthopedics, Nursing, And Contraception (AREA)

FR12C0005C 1996-10-08 2012-01-19 Utilisation d'une composition estroprogestative en tant que contraceptif oral Active FR12C0005I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9612239A FR2754179B1 (fr)	1996-10-08	1996-10-08	Nouvelle composition hormononale et son utilisation
EP97944940A EP0956022B1 (fr)	1996-10-08	1997-10-08	Composition hormonale constituee d'un compose estrogene et d'un compose progestatif

Publications (2)

Publication Number	Publication Date
FR12C0005I1 FR12C0005I1 (fr)	2012-02-24
FR12C0005I2 true FR12C0005I2 (fr)	2016-06-24

Family

ID=9496456

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
FR9612239A Expired - Fee Related FR2754179B1 (fr)	1996-10-08	1996-10-08	Nouvelle composition hormononale et son utilisation
FR12C0005C Active FR12C0005I2 (fr)	1996-10-08	2012-01-19	Utilisation d'une composition estroprogestative en tant que contraceptif oral

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
FR9612239A Expired - Fee Related FR2754179B1 (fr)	1996-10-08	1996-10-08	Nouvelle composition hormononale et son utilisation

Country Status (38)

Country	Link
US (4)	US6831073B1 (fr)
EP (2)	EP1334725B1 (fr)
JP (1)	JP4883542B2 (fr)
KR (2)	KR100782638B1 (fr)
CN (3)	CN101229173A (fr)
AP (1)	AP1171A (fr)
AR (2)	AR009113A1 (fr)
AT (2)	ATE353652T1 (fr)
AU (1)	AU745571B2 (fr)
BR (1)	BR9712274A (fr)
CA (1)	CA2268358C (fr)
CL (1)	CL2011000017A1 (fr)
CZ (1)	CZ298402B6 (fr)
DE (3)	DE69737373T2 (fr)
DK (2)	DK0956022T3 (fr)
DZ (1)	DZ2327A1 (fr)
ES (2)	ES2198006T3 (fr)
FR (2)	FR2754179B1 (fr)
HK (1)	HK1210708A1 (fr)
HU (2)	HU227450B1 (fr)
ID (1)	ID21569A (fr)
IL (1)	IL129194A (fr)
LU (1)	LU91932I2 (fr)
MA (1)	MA24370A1 (fr)
MY (1)	MY128482A (fr)
NO (3)	NO324357B1 (fr)
NZ (1)	NZ334876A (fr)
OA (1)	OA11033A (fr)
PL (1)	PL192979B1 (fr)
PT (2)	PT1334725E (fr)
RU (1)	RU2274450C2 (fr)
SK (2)	SK285056B6 (fr)
TN (1)	TNSN97164A1 (fr)
TR (1)	TR199900764T2 (fr)
TW (1)	TW491704B (fr)
WO (1)	WO1998015279A1 (fr)
YU (1)	YU18099A (fr)
ZA (1)	ZA979011B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4344462C2 (de)	1993-12-22	1996-02-01	Schering Ag	Zusammensetzung für die Empfängnisverhütung
DE19549264A1 (de) *	1995-12-23	1997-06-26	Schering Ag	Verfahren und Kit zur Kontrazeption
FR2754179B1 (fr)	1996-10-08	1998-12-24	Theramex	Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) *	1999-10-25	2001-05-03	Laboratoire Theramex	Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
WO2001030356A1 (fr) *	1999-10-25	2001-05-03	Laboratoire Theramex	Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) *	2000-09-15	2003-03-07	Theramex	Nouvelles compositions estro-progestatives topiques a effet systemique
FR2823976A1 (fr) *	2001-04-25	2002-10-31	Theramex	Nouvelle composition hormonale et son utilisation
UY29185A1 (es) *	2004-11-02	2006-05-31	Schering Ag	Formas de dosificación oral sólidas que contienen una dosis baja de estradiol
PE20081895A1 (es)	2007-03-26	2009-01-26	Theramex	Regimen anticonceptivo oral
RU2332219C1 (ru) *	2007-03-30	2008-08-27	Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО БГМУ РОСЗДРАВА)	Средство для модуляции плотности н2-гистаминовых рецепторов сердца при менопаузе
US20080293683A1 (en) *	2007-05-24	2008-11-27	University Of Kansas Medical Center	Hormone Replacement Therapy
AR066166A1 (es) *	2007-09-21	2009-07-29	Organon Nv	Sistema de suministro de droga
US10413504B2 (en)	2013-12-11	2019-09-17	Merck Sharp & Dohme Corp.	Intravaginal ring drug delivery system
EP3079659B1 (fr)	2013-12-11	2020-10-28	Merck Sharp & Dohme B.V.	Système d'administration de médicaments pour la fourniture d'antiviraux
US20230398127A1 (en) *	2020-10-16	2023-12-14	Theramex HQ UK Limited	Use of combined oral contraceptives containing nomegestrol acetate and estradiol
KR102744791B1 (ko)	2022-07-05	2024-12-19	주식회사 이음정보	소멸특허 관리 및 특허거래 시스템

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3271392A (en) *	1965-09-14	1966-09-06	American Home Prod	17alpha-[3'-furyl]-estrogens
US4390531A (en)	1981-08-10	1983-06-28	Syntex Pharmaceuticals International Ltd.	Method of contraception using peak progestogen dosage
US4921843A (en)	1988-10-20	1990-05-01	Pasquale Samuel A	Contraception system and method
US4826831A (en)	1983-08-05	1989-05-02	Pre Jay Holdings Limited	Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4628051A (en)	1983-09-26	1986-12-09	Ortho Pharmaceutical Corporation	Triphasic oral contraceptive
JPS61243059A (ja)	1985-04-19	1986-10-29	Konishi Kagaku Kogyo Kk	高純度４，４′−ジヒドロキシジフエニルスルホンの製造法
US5208225A (en)	1986-02-27	1993-05-04	Warner-Lambert Company	Compositions containing fixed combinations
ZA87332B (en)	1986-02-27	1987-08-26	Warner Lambert Co	Compositions containing fixed combinations
US5145682A (en) *	1986-05-30	1992-09-08	Rutgers, The State University Of New Jersey	Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
DK174724B1 (da)	1986-07-15	2003-10-06	Wyeth Corp	Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
CA1332227C (fr)	1987-09-24	1994-10-04	Robert F. Casper	Formule de contraceptif oral
US5276022A (en)	1987-09-24	1994-01-04	Jencap Research Ltd.	Hormone preparation and method
FI101601B1 (fi) *	1987-09-24	1998-07-31	Jencap Research Ltd	Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmisteen valmistusmenetelmässä
US5108995A (en)	1987-09-24	1992-04-28	Jencap Research Ltd.	Hormone preparation and method
US5256421A (en)	1987-09-24	1993-10-26	Jencap Research Ltd.	Hormone preparation and method
HUT52382A (en)	1988-03-14	1990-07-28	Sandoz Ag	Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
IE71203B1 (en)	1990-12-13	1997-02-12	Akzo Nv	Low estrogen oral contraceptives
IE62665B1 (en)	1990-12-17	1995-02-22	Akzo Nv	Contraceptive regimen
FR2695826B1 (fr) *	1992-09-21	1995-01-06	Theramex	Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
US6150343A (en)	1993-06-30	2000-11-21	University Of Pittsburgh	Camptothecin analogs and methods of preparation thereof
US5554601A (en) *	1993-11-05	1996-09-10	University Of Florida	Methods for neuroprotection
DE4344462C2 (de) *	1993-12-22	1996-02-01	Schering Ag	Zusammensetzung für die Empfängnisverhütung
US5552394A (en) *	1994-07-22	1996-09-03	The Medical College Of Hampton Roads	Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6613757B1 (en)	1994-09-22	2003-09-02	Board Of Regents, The University Of Texas System	Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
SE9403389D0 (sv)	1994-10-06	1994-10-06	Astra Ab	Pharmaceutical composition containing derivattves of sex hormones
FR2737411B1 (fr) *	1995-08-01	1997-10-17	Theramex	Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
DE19540253C2 (de)	1995-10-28	1998-06-04	Jenapharm Gmbh	Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
DE19549264A1 (de)	1995-12-23	1997-06-26	Schering Ag	Verfahren und Kit zur Kontrazeption
AU2926897A (en)	1996-05-08	1997-11-26	American Home Products Corporation	Oral contraceptive
WO1997041868A1 (fr)	1996-05-08	1997-11-13	American Home Products Corporation	Contraceptif oral
WO1997041869A1 (fr)	1996-05-08	1997-11-13	American Home Products Corporation	Contraceptif oral
AU2926997A (en)	1996-05-08	1997-11-26	American Home Products Corporation	Oral contraceptive
AU2746097A (en)	1996-05-08	1997-11-26	American Home Products Corporation	Oral contraceptive
AU3888697A (en)	1996-07-26	1998-02-20	American Home Products Corporation	Progestin/estrogen oral contraceptive
WO1998004265A1 (fr)	1996-07-26	1998-02-05	American Home Products Corporation	Methode contraceptive a deux phases et kit comportant une combinaison d'une progestine et d'un oestrogene
AU3961697A (en)	1996-07-26	1998-02-20	American Home Products Corporation	Oral contraceptive
US5888543A (en) *	1996-07-26	1999-03-30	American Home Products Corporation	Oral contraceptives
DK0917466T3 (da)	1996-07-26	2004-12-20	Wyeth Corp	Oralt antikonceptionsmiddel
AU3888597A (en)	1996-07-26	1998-02-20	American Home Products Corporation	Oral contraceptive
FR2754179B1 (fr)	1996-10-08	1998-12-24	Theramex	Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr)	1999-10-25	2001-05-03	Laboratoire Theramex	Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
DE19705229C2 (de)	1997-02-12	1999-04-15	Hesch Rolf Dieter Prof Dr Med	Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US5898032A (en)	1997-06-23	1999-04-27	Medical College Of Hampton Roads	Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
ATE279198T1 (de)	1997-08-27	2004-10-15	Ortho Mcneil Pharm Inc	Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
DE19739916C2 (de) *	1997-09-11	2001-09-13	Hesch Rolf Dieter	Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
EP1011681A1 (fr)	1997-09-12	2000-06-28	American Home Products Corporation	Preparation contraceptive orale comportant une premiere phase a base de progestine/oestrogene et une seconde phase a base de progestine
WO2001030356A1 (fr)	1999-10-25	2001-05-03	Laboratoire Theramex	Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation

1996
- 1996-10-08 FR FR9612239A patent/FR2754179B1/fr not_active Expired - Fee Related
1997
- 1997-10-07 TN TNTNSN97164A patent/TNSN97164A1/fr unknown
- 1997-10-08 ID IDW990211A patent/ID21569A/id unknown
- 1997-10-08 CA CA2268358A patent/CA2268358C/fr not_active Expired - Lifetime
- 1997-10-08 RU RU2003107072/15A patent/RU2274450C2/ru active
- 1997-10-08 TR TR1999/00764T patent/TR199900764T2/xx unknown
- 1997-10-08 DZ DZ970177A patent/DZ2327A1/fr active
- 1997-10-08 DE DE69737373T patent/DE69737373T2/de not_active Expired - Lifetime
- 1997-10-08 PL PL332610A patent/PL192979B1/pl unknown
- 1997-10-08 NZ NZ334876A patent/NZ334876A/xx not_active IP Right Cessation
- 1997-10-08 MA MA24828A patent/MA24370A1/fr unknown
- 1997-10-08 MY MYPI97004717A patent/MY128482A/en unknown
- 1997-10-08 PT PT03008979T patent/PT1334725E/pt unknown
- 1997-10-08 CN CNA2007101694575A patent/CN101229173A/zh active Pending
- 1997-10-08 AT AT03008979T patent/ATE353652T1/de active
- 1997-10-08 DK DK97944940T patent/DK0956022T3/da active
- 1997-10-08 SK SK438-99A patent/SK285056B6/sk not_active IP Right Cessation
- 1997-10-08 ES ES97944940T patent/ES2198006T3/es not_active Expired - Lifetime
- 1997-10-08 AT AT97944940T patent/ATE238057T1/de active
- 1997-10-08 AU AU46273/97A patent/AU745571B2/en not_active Expired
- 1997-10-08 CN CN201510024865.6A patent/CN104706641A/zh active Pending
- 1997-10-08 CZ CZ0112099A patent/CZ298402B6/cs not_active IP Right Cessation
- 1997-10-08 YU YU18099A patent/YU18099A/sh unknown
- 1997-10-08 BR BR9712274-2A patent/BR9712274A/pt not_active Application Discontinuation
- 1997-10-08 ZA ZA9709011A patent/ZA979011B/xx unknown
- 1997-10-08 CN CN97180380A patent/CN1239893A/zh active Pending
- 1997-10-08 DE DE69721314T patent/DE69721314T2/de not_active Expired - Lifetime
- 1997-10-08 WO PCT/FR1997/001792 patent/WO1998015279A1/fr not_active Ceased
- 1997-10-08 PT PT97944940T patent/PT956022E/pt unknown
- 1997-10-08 US US09/284,147 patent/US6831073B1/en not_active Expired - Lifetime
- 1997-10-08 AR ARP970104638A patent/AR009113A1/es not_active Application Discontinuation
- 1997-10-08 HU HU9904508A patent/HU227450B1/hu active Protection Beyond IP Right Term
- 1997-10-08 EP EP03008979A patent/EP1334725B1/fr not_active Expired - Lifetime
- 1997-10-08 IL IL12919497A patent/IL129194A/xx not_active IP Right Cessation
- 1997-10-08 SK SK5098-2005A patent/SK285455B6/sk active Protection Beyond IP Right Term
- 1997-10-08 JP JP51726398A patent/JP4883542B2/ja not_active Expired - Lifetime
- 1997-10-08 ES ES03008979T patent/ES2282539T3/es not_active Expired - Lifetime
- 1997-10-08 EP EP97944940A patent/EP0956022B1/fr not_active Expired - Lifetime
- 1997-10-08 KR KR1020067013702A patent/KR100782638B1/ko not_active Expired - Lifetime
- 1997-10-08 AP APAP/P/1999/001500A patent/AP1171A/en active
- 1997-10-08 KR KR1019990703032A patent/KR20000048981A/ko not_active Withdrawn
- 1997-10-08 DK DK03008979T patent/DK1334725T3/da active
- 1997-10-15 TW TW086115281A patent/TW491704B/zh not_active IP Right Cessation
1999
- 1999-03-31 NO NO19991593A patent/NO324357B1/no not_active IP Right Cessation
- 1999-04-08 OA OA9900078A patent/OA11033A/fr unknown
- 1999-10-25 US US09/423,108 patent/US6906049B1/en not_active Expired - Lifetime
2004
- 2004-01-08 US US10/753,073 patent/US20040220163A1/en not_active Abandoned
2007
- 2007-01-03 US US11/649,672 patent/US7749987B2/en not_active Expired - Fee Related
2009
- 2009-10-26 AR ARP090104109A patent/AR073972A2/es not_active Application Discontinuation
2011
- 2011-01-06 CL CL2011000017A patent/CL2011000017A1/es unknown
2012
- 2012-01-13 LU LU91932C patent/LU91932I2/fr unknown
- 2012-01-19 FR FR12C0005C patent/FR12C0005I2/fr active Active
- 2012-01-23 DE DE201212000010 patent/DE122012000010I1/de active Pending
- 2012-01-24 NO NO2012002C patent/NO2012002I2/no not_active IP Right Cessation
- 2012-01-26 HU HUS1200002C patent/HUS1200002I1/hu unknown
2015
- 2015-11-24 HK HK15111561.9A patent/HK1210708A1/xx unknown
2017
- 2017-08-08 NO NO2017043C patent/NO2017043I2/no unknown

Also Published As

Publication number	Publication date
KR100782638B1 (ko)	2007-12-06
ES2198006T3 (es)	2004-01-16
YU18099A (sh)	2002-03-18
DZ2327A1 (fr)	2002-12-28
CL2011000017A1 (es)	2011-06-24
NO2017043I1 (no)	2017-08-08
AR009113A1 (es)	2000-03-08
EP0956022A1 (fr)	1999-11-17
EP1334725A3 (fr)	2004-01-21
CN104706641A (zh)	2015-06-17
CA2268358C (fr)	2010-04-20
ID21569A (id)	1999-06-24
DE69737373D1 (de)	2007-03-29
DK1334725T3 (da)	2007-06-11
LU91932I9 (fr)	2018-12-27
HK1210708A1 (en)	2016-05-06
PT1334725E (pt)	2007-05-31
ZA979011B (en)	1998-06-03
CA2268358A1 (fr)	1998-04-16
KR20000048981A (ko)	2000-07-25
HU227450B1 (en)	2011-06-28
HUP9904508A2 (hu)	2000-06-28
NO2017043I2 (no)	2019-01-25
AU745571B2 (en)	2002-03-21
SK285056B6 (sk)	2006-05-04
DE69721314D1 (de)	2003-05-28
DE122012000010I1 (de)	2012-04-19
EP0956022B1 (fr)	2003-04-23
FR12C0005I1 (fr)	2012-02-24
LU91932I2 (fr)	2012-03-13
AR073972A2 (es)	2010-12-15
IL129194A (en)	2003-06-24
AP1171A (en)	2003-06-30
PT956022E (pt)	2003-07-31
NO991593L (no)	1999-06-07
FR2754179A1 (fr)	1998-04-10
NO324357B1 (no)	2007-10-01
ATE238057T1 (de)	2003-05-15
JP4883542B2 (ja)	2012-02-22
ATE353652T1 (de)	2007-03-15
PL192979B1 (pl)	2006-12-29
US6906049B1 (en)	2005-06-14
SK285455B6 (sk)	2007-01-04
IL129194A0 (en)	2000-02-17
FR2754179B1 (fr)	1998-12-24
CN101229173A (zh)	2008-07-30
CN1239893A (zh)	1999-12-29
WO1998015279A1 (fr)	1998-04-16
HUP9904508A3 (en)	2001-01-29
EP1334725A2 (fr)	2003-08-13
KR20060084864A (ko)	2006-07-25
US20040220163A1 (en)	2004-11-04
CZ298402B6 (cs)	2007-09-19
NZ334876A (en)	2001-06-29
MA24370A1 (fr)	1998-07-01
US6831073B1 (en)	2004-12-14
SK43899A3 (en)	1999-12-10
NO2012002I1 (no)	2012-01-24
TW491704B (en)	2002-06-21
DE69721314T2 (de)	2004-02-12
DK0956022T3 (da)	2003-08-04
TR199900764T2 (xx)	1999-07-21
MY128482A (en)	2007-02-28
AP9901500A0 (en)	1999-06-30
JP2002509524A (ja)	2002-03-26
US7749987B2 (en)	2010-07-06
RU2274450C2 (ru)	2006-04-20
DE69737373T2 (de)	2007-06-21
BR9712274A (pt)	1999-08-31
HUS1200002I1 (hu)	2016-08-29
AU4627397A (en)	1998-05-05
NO2012002I2 (no)	2013-04-02
OA11033A (fr)	2003-03-06
TNSN97164A1 (fr)	1999-12-31
US20070281912A1 (en)	2007-12-06
ES2282539T3 (es)	2007-10-16
EP1334725B1 (fr)	2007-02-14
PL332610A1 (en)	1999-09-27
NO991593D0 (no)	1999-03-31
CZ9901120A3 (cs)	2000-11-15

Publication	Publication Date	Title
FR12C0005I2 (fr)	2016-06-24	Utilisation d'une composition estroprogestative en tant que contraceptif oral
DE19681287T1 (de)	1998-03-19	Orale Formulierung von 2-Methylthienobenzodiazepin
FI963421A0 (fi)	1996-09-02	Oraalisia apuainekoostumuksia
PT721337E (pt)	2002-05-31	Formulacoes orais de um antifungico
BR9509200A (pt)	1997-12-30	Composição de matéria
ATE304359T1 (de)	2005-09-15	Anti-östrogen- und progestin-enthaltende orale kontrazeptiva
PT1014987E (pt)	2004-06-30	Composicoes orais de levosimendano
FR2726906B1 (fr)	1997-08-29	Instrument d'indication
BR9612555A (pt)	1999-07-20	Composições de detergente que contêm precursores de fragância e os precursores de fragância dessas composições
DE19781549T1 (de)	1999-03-11	Desinfektionszusammensetzung "Weltolen"
PT906101E (pt)	2002-09-30	Formulacoes farmaceuticas de libertacao prolongada contendo mizolastina
ID16838A (id)	1997-11-13	Komposisi dekafluoropentana
DE59709372D1 (de)	2003-04-03	Riechstoffkompositionen enthaltend substituierte 2-Acetylbenzofurane
ID17419A (id)	1997-12-24	Komposisi dekafluoropentana
FR2710673B1 (fr)	1995-12-08	Composition d'enduit de parement.
ID24232A (id)	2000-07-13	Komposisi bahan pendingin non-korosif
FR2756310B1 (fr)	1999-01-15	Montant auxiliaire d'echafaudage
MD249F1 (ro)	1995-07-31	Compozitie de ingrediente pentru lichiorul "nocturn"
UA1629S (uk)	1997-10-31	Набір фестонів "веснянка-5"
UA25803A (uk)	1998-12-25	Композиція іhгредієhтів бальзаму "старий доктор"
UA25802A (uk)	1998-12-25	Композиція іhгредієhтів бальзаму "старий доктор"
UA25801A (uk)	1998-12-25	Композиція іhгредієhтів бальзаму "старий доктор"
UA1693S (uk)	1997-12-25	Набір етикеток "суми"
UA1957S (uk)	1998-04-30	Етикетка медичного препарату "аспаркам"
UA1951S (uk)	1998-04-30	Етикетка медичного препарату "валідол"